0001209191-22-039712.txt : 20220628
0001209191-22-039712.hdr.sgml : 20220628
20220628210047
ACCESSION NUMBER: 0001209191-22-039712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220624
FILED AS OF DATE: 20220628
DATE AS OF CHANGE: 20220628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freeman Roy Lester
CENTRAL INDEX KEY: 0001799732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39676
FILM NUMBER: 221051568
MAIL ADDRESS:
STREET 1: 256 SUMMIT AVE
CITY: BROOKLINE
STATE: MA
ZIP: 02446
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001750149
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
BUSINESS PHONE: 678-392-3419
MAIL ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-24
0
0001750149
Inhibikase Therapeutics, Inc.
IKT
0001799732
Freeman Roy Lester
C/O 3350 RIVERWOOD PARKWAY SE
SUITE 1900
ATLANTA
GA
30339
1
0
0
0
Stock Option (right to buy)
0.81
2022-06-24
4
A
0
40000
0.00
A
2029-06-24
Common Stock
40000
40000
D
This entire stock option grant will vest 100% in a single tranche on the earlier of June 24, 2023 or the day prior to the next annual meeting of stockholders.
/s/ Milton H. Werner, attorney-in-fact
2022-06-28